Search research articles
Contact Us
Filters
Showing results (151-160 of 162) with videos related to
Page
of 17
Sort By:
Neuro-Oncology Advances
|
July 10, 2020
EGFR mutations are associated with response to depatux-m in combination with temozolomide and result in a receptor that is hypersensitive to ligand
Youri Hoogstrate, Wies Vallentgoed, Johan M Kros, et al.
Neuro-Oncology
|
November 21, 2019
INTELLANCE 2/EORTC 1410 randomized phase II study of Depatux-M alone and with temozolomide vs temozolomide or lomustine in recurrent EGFR amplified glioblastoma
Martin Van Den Bent, Marica Eoli, Juan Manuel Sepulveda, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 18, 2021
Impact of depatuxizumab mafodotin on health-related quality of life and neurological functioning in the phase II EORTC 1410/INTELLANCE 2 trial for EGFR-amplified recurrent glioblastoma
Paul M J Clement, Linda Dirven, Marica Eoli, et al.
The New England Journal of Medicine
|
March 16, 2017
Short-Course Radiation plus Temozolomide in Elderly Patients with Glioblastoma
James R Perry, Normand Laperriere, Christopher J O'Callaghan, et al.
The Lancet Regional Health. Europe
|
February 22, 2024
Management of patients with rare adult solid cancers: objectives and evaluation of European reference networks (ERN) EURACAN
Jean-Yves Blay, Paolo Casali, Isabelle Ray-Coquard, et al.
The Lancet. Oncology
|
December 5, 2019
EANO-EURACAN clinical practice guideline for diagnosis, treatment, and follow-up of post-pubertal and adult patients with medulloblastoma
Enrico Franceschi, Silvia Hofer, Alba A Brandes, et al.
Cancers
|
July 24, 2021
Development of Randomized Trials in Adults with Medulloblastoma-The Example of EORTC 1634-BTG/NOA-23
Peter Hau, Didier Frappaz, Elizabeth Hovey, et al.
Neuro-Oncology
|
February 14, 2022
Prospective validation of a new imaging scorecard to assess leptomeningeal metastasis: A joint EORTC BTG and RANO effort
Emilie Le Rhun, Patrick Devos, Sebastian Winklhofer, et al.
Nature Cancer
|
August 19, 2025
Evolutionary trajectories of IDH-mutant astrocytoma identify molecular grading markers related to cell cycling
Wies R Vallentgoed, Youri Hoogstrate, Karin A van Garderen, et al.
Neuro-Oncology
|
October 5, 2021
The EGFRvIII transcriptome in glioblastoma: A meta-omics analysis
Youri Hoogstrate, Santoesha A Ghisai, Maurice de Wit, et al.
Page
of 17
Search research articles
Search
Showing results (151-160 of 162) with videos related to
Sort By:
Page
of 17
Neuro-Oncology Advances
|
July 10, 2020
EGFR mutations are associated with response to depatux-m in combination with temozolomide and result in a receptor that is hypersensitive to ligand
Youri Hoogstrate, Wies Vallentgoed, Johan M Kros, et al.
Neuro-Oncology
|
November 21, 2019
INTELLANCE 2/EORTC 1410 randomized phase II study of Depatux-M alone and with temozolomide vs temozolomide or lomustine in recurrent EGFR amplified glioblastoma
Martin Van Den Bent, Marica Eoli, Juan Manuel Sepulveda, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 18, 2021
Impact of depatuxizumab mafodotin on health-related quality of life and neurological functioning in the phase II EORTC 1410/INTELLANCE 2 trial for EGFR-amplified recurrent glioblastoma
Paul M J Clement, Linda Dirven, Marica Eoli, et al.
The New England Journal of Medicine
|
March 16, 2017
Short-Course Radiation plus Temozolomide in Elderly Patients with Glioblastoma
James R Perry, Normand Laperriere, Christopher J O'Callaghan, et al.
The Lancet Regional Health. Europe
|
February 22, 2024
Management of patients with rare adult solid cancers: objectives and evaluation of European reference networks (ERN) EURACAN
Jean-Yves Blay, Paolo Casali, Isabelle Ray-Coquard, et al.
The Lancet. Oncology
|
December 5, 2019
EANO-EURACAN clinical practice guideline for diagnosis, treatment, and follow-up of post-pubertal and adult patients with medulloblastoma
Enrico Franceschi, Silvia Hofer, Alba A Brandes, et al.
Cancers
|
July 24, 2021
Development of Randomized Trials in Adults with Medulloblastoma-The Example of EORTC 1634-BTG/NOA-23
Peter Hau, Didier Frappaz, Elizabeth Hovey, et al.
Neuro-Oncology
|
February 14, 2022
Prospective validation of a new imaging scorecard to assess leptomeningeal metastasis: A joint EORTC BTG and RANO effort
Emilie Le Rhun, Patrick Devos, Sebastian Winklhofer, et al.
Nature Cancer
|
August 19, 2025
Evolutionary trajectories of IDH-mutant astrocytoma identify molecular grading markers related to cell cycling
Wies R Vallentgoed, Youri Hoogstrate, Karin A van Garderen, et al.
Neuro-Oncology
|
October 5, 2021
The EGFRvIII transcriptome in glioblastoma: A meta-omics analysis
Youri Hoogstrate, Santoesha A Ghisai, Maurice de Wit, et al.
Page
of 17